Journal Guide

Current Biology is widely valued among life scientists for its unique blend of important research papers and informed, lively commentary. Published every 2 weeks, the journal delivers exciting primary research from all areas of biology, from molecular biology to evolution. Current Biology also features timely Dispatches - commentary by leading experts on the latest advances - as well as valuable full-length reviews and a vibrant magazine section that includes news, analysis and opinion, profiles of leading scientists and institutions, and informative, accessible guides to notable topics in biology.Current Biology features research and commentary in all areas of biology, including:Cell Biology, Cell Signaling, Cell Cycle Regulation, and ApoptosisDevelopmental BiologyCellular and Systems NeuroscienceCancer BiologyGene Expression, including Genomics & ProteomicsDNA and RNA Metabolism, including Transcription and TranslationPlant BiologyImmunologyEcology and EvolutionCurrent Biology has earnerd a leading Impact Factor among biology journals of its scope. Visit the Current Biology website to learn more.

Current Biotechnology publishes critical and authoritative reviews, original research and methodology articles, and thematic issues in all areas of biotechnology, including basic and applied research. The journal serves as an advanced forum for innovative studies and major trends at the interface of technology, life sciences and biomedicine. Our aim is to provide a comprehensive and reliable source of information on the current advances and future perspectives in key themes of biotechnology.

The aim of this journal is to help readers understand expert views on current advances in the field of bladder dysfunction by systematically providing review articles that highlight the most important papers recently published.

We accomplish this aim by appointing major authorities in key subject areas across the discipline to select topics reviewed by leading experts who emphasize recent developments, novel research, and highlight important papers published over the past year on their topics. We also highlight areas that have not received attention in the past and are important to an international audience, such a voiding dysfunction in reconstructed bladders and voiding dysfunction associated with genitourinary infections. An Editorial Board of internationally diverse members also suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

Cardiovascular imaging technologies now play an expanded role in clinical practice. Beyond the diagnosis of a disease process, these techniques are rapidly transitioning to help guide therapy. The journal aims to keep readers current with rapidly evolving advances in instrumentation and imaging procedures that support the expanded role of these technologies in clinical practice. The journal intends to place the entire area of cardiovascular imaging in its proper prospective by establishing the indications and limitations of each imaging technique and by summarizing recent clinical advances.

We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas across the field, including cardiac magnetic resonance, nuclear imaging, echocardiography, cardiac computed tomography, intravascular, molecular, and hybrid imaging. Section Editors select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists.  An Editorial Board of internationally diverse members ensures that topics include emerging research and suggests topics of special interest to their country/region. We also provide commentaries from well-known figures in the field. 

Current Chemical Biology aims to publish full-length and mini reviews as well as research papers on exciting new developments at the chemistry-biology interface, covering topics relating to Chemical Synthesis, Science at Chemistry-Biology Interface and Chemical Mechanisms of Biological Systems.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Current Diabetes Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited issues on all the latest advances on diabetes and its related areas dedicated to clinical research e.g. pharmacology, pathogenesis, complications, epidemiology, clinical care and therapy.

Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism, pharmacokinetics, and drug disposition. The journal serves as an international forum for the publication of full-length/mini review, research articles and guest edited issues in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the most important developments. The journal covers the following general topic areas: pharmaceutics, pharmacokinetics, toxicology, and most importantly drug metabolism.
More specifically, in vitro and in vivo drug metabolism of phase I and phase II enzymes or metabolic pathways; drug-drug interactions and enzyme kinetics; pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, and toxicokinetics; interspecies differences in metabolism or pharmacokinetics, species scaling and extrapolations; drug transporters; target organ toxicity and interindividual variability in drug exposure-response; extrahepatic metabolism; bioactivation, reactive metabolites, and developments for the identification of drug metabolites. Preclinical and clinical reviews describing the drug metabolism and pharmacokinetics of marketed drugs or drug classes.

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Enzyme Inhibition aims to publish original research, review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases. Cell therapy manuscripts can also include application in non-genetic diseases when cells have been genetically modified. Current Gene Therapy publishes reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of genetic diseases.

Current Genetics publishes peer-reviewed articles presenting genetic, genomic, molecular and systems-level analysis of eukaryotic and prokaryotic microorganisms and cell organelles. We welcome submissions employing any type of research approach, be it analytical (aiming at a better understanding), applied (aiming at practical applications), synthetic or theoretical.

is a peer-reviewed journal that provides essential reading about the latest and most important developments in genome science and related fields of research. Systems biology, systems modeling, machine learning, network inference, bioinformatics, computational biology, epigenetics, single cell genomics, extracellular vesicles, quantitative biology, and synthetic biology for the study of evolution, development, maintenance, aging and that of human health, human diseases, clinical genomics and precision medicine are topics of particular interest. The journal covers plant genomics. The journal will not consider articles dealing with breeding and livestock.

Current Hematologic Malignancy Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal elucidates current and emerging approaches to the diagnosis, treatment, management, and prevention of conditions associated with hematologic malignancy.

Current Issues in Molecular Biology (CIMB) publishes high quality critical reviews and minireviews, in English, in all areas of molecular biology, microbiology, genomics and biotechnology. Articles describing innovative technology of general interest to molecular biologists and biomedical scientists will also be considered for publication.Papers are selected on the basis of topicality, originality, objectivity, and relevance to a broad readership encompassing research scientists, biomedical scientists, and health professionals. All manuscripts undergo a peer-review process.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews and guest edited thematic issues written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Current Metabolomics and Systems Biology publishes full-length/mini reviews, original research articles, thematic issues, and technical notes covering all aspects of the recent advancements and applications of Omics technology to systems biology, disease diagnosis, personalized medicine, drug discovery, toxicity, nutrition and food, environmental studies, and functional genomics. While the journal emphasis metabolomics, manuscripts describing the application of other Omics technology (e.g., genomics, proteomics, and transcriptomics), especially in combination with metabolomics, to systems biology are also welcome. This includes the application of Omics technology to clinical studies. Manuscripts appropriate for Current Metabolomics and Systems Biology should emphasize the application, development or enhancement of OMICS technology.